Staff profile
Dr Christopher Adda
Research Fellow
Faculty of Science, Technology and Engineering
School of Molecular SciencesDepartment of Biochemistry
La Trobe Institute for Molecular Science
Melbourne (Bundoora)
- T: +61 3 9479 1157
- F: +61 3 9479 1266
- E: C.Adda@latrobe.edu.au
Qualifications
BSc(Hons), PhD (La Trobe), Post Grad Diploma, Innovation Management
Membership of professional Associations
Australian Society for Biochemistry and Molecular Biology
Area of study
Biochemistry and Molecular Biology
Recent Publications
Zhang X, Adda CG, Low A, Zhang J, Zhang W, Sun H, Tu X, Anders RF, Norton RS. (2012) Role of the helical structure of the N-terminal region of Plasmodium falciparum merozoite surface protein 2 in fibril formation and membrane interaction. Biochemistry. 51(7):1380-7.
McCarthy JS, Marjason J, Elliott S, Fahey P, Bang G, Malkin E, Tierney E, Aked-Hurditch H, Adda C, Cross N, Richards JS, Fowkes FJ, Boyle MJ, Long C, Druilhe P, Beeson JG, Anders RF. (2011) A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide® ISA 720. PLoS One. 6(9):e24413
Chandrashekaran IR, Adda CG, Macraild CA, Anders RF, Norton RS. (2011) EGCG disaggregates amyloid-like fibrils formed by Plasmodium falciparum merozoite surface protein 2. Arch Biochem Biophys. 513(2):153-7.
Chandrashekaran IR, Adda CG, MacRaild CA, Anders RF, Norton RS. (2010) Inhibition by flavonoids of amyloid-like fibril formation by Plasmodium falciparum merozoite surface protein 2. Biochemistry. 49(28):5899-908.
Yang X, Adda CG, MacRaild CA, Low A, Zhang X, Zeng W, Jackson DC, Anders RF, Norton RS. (2010) Identification of key residues involved in fibril formation by the conserved N-terminal region of Plasmodium falciparum merozoite surface protein 2 (MSP2). Biochimie. 92(10):1287-95.
Anders RF, Adda CG, Foley M, Norton RS. (2010) Recombinant protein vaccines against the asexual blood stages of Plasmodium falciparum. Hum Vaccin. 6(1):39-53.
